Insider · CIK 0001959229
Peter Rahmer
Files at RLAY (Relay Therapeutics, Inc.). First filing Oct 30, 2024, latest Jul 30, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RLAY: Relay Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | Relay Therapeutics, Inc. | $63k 17,083 shares | -4% | +85% from low-54% from high | |
| 36Weak | Relay Therapeutics, Inc. | $37k 12,103 shares | -3% | +63% from low-60% from high | |
| 30Weak | Relay Therapeutics, Inc. | $1,752 400 shares | -0% | - | |
| 30Weak | Relay Therapeutics, Inc. | $9,823 1,621 shares | -0% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 28, 2025 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock | -1,359 | $3.74 | $5,083 | 393,722 | Jul 30, 2025 |
| Jul 29, 2025 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock | -15,724 | $3.68 | $58k | 377,998 | Jul 30, 2025 |
| Jun 30, 2025 | RLAY Relay Therapeutics, Inc. | AGrant or award Common Stock | +5,000 | $2.94 | $15k | 395,081 | Jul 1, 2025 |
| Apr 28, 2025 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock | -1,364 | $3.17 | $4,324 | 400,820 | Apr 30, 2025 |
| Apr 30, 2025 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock | -10,739 | $3.00 | $32k | 390,081 | Apr 30, 2025 |
| Dec 27, 2024 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock | -400 | $4.38 | $1,752 | 389,663 | Dec 31, 2024 |
| Oct 28, 2024 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock | -1,621 | $6.06 | $9,823 | 390,063 | Oct 30, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.